Graham Walmsley
Director/Board Member bij AKERO THERAPEUTICS, INC.
Vermogen: 54 764 $ op 31-03-2024
Actieve functies van Graham Walmsley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 01-06-2018 | - |
| Independent Dir/Board Member | 01-06-2018 | - | |
| OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 01-03-2020 | - |
| Independent Dir/Board Member | 01-03-2020 | - | |
Logos Capital Fund LLP
 Logos Capital Fund LLP Investment Trusts/Mutual FundsMiscellaneous Logos Capital Fund LLP functions as pooled investment fund. The company is headquartered in Rehoboth, DE. | Founder | 01-08-2019 | - |
| Corporate Officer/Principal | 01-08-2019 | - | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The private company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Director/Board Member | 01-02-2020 | - |
Logos Global Management LP
 Logos Global Management LP Investment ManagersFinance Logos Global Management LP (Logos) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Arsani William and Graham Walmsley in 2019. They are owned and controlled by Logos Global Management GP LLC. Logos provides discretionary investment management services to privately offered pooled investment vehicles. | Founder | 01-03-2019 | - |
| Portfolio Manager-Equities | 01-03-2019 | - |
Loopbaan van Graham Walmsley
Eerdere bekende functies van Graham Walmsley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Director/Board Member | 01-04-2020 | 01-08-2021 |
| Independent Dir/Board Member | 01-04-2020 | 01-08-2021 | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Private Equity Investor | 01-07-2016 | 01-08-2019 |
| Corporate Officer/Principal | 01-07-2016 | 01-08-2019 | |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-06-2017 | 01-03-2019 |
| CONTINEUM THERAPEUTICS, INC. | Corporate Officer/Principal | 01-04-2018 | 01-12-2018 |
| ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Graham Walmsley
| University of California, Berkeley | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 14 |
Operationeel
| Director/Board Member | 6 |
| Corporate Officer/Principal | 4 |
| Independent Dir/Board Member | 4 |
Sectoraal
| Health Technology | 6 |
| Finance | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| AKERO THERAPEUTICS, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| SCIENCE 37 HOLDINGS, INC. | Commercial Services |
| Bedrijven in privébezit | 6 |
|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Logos Capital Fund LLP
Logos Capital Fund LLP Investment Trusts/Mutual FundsMiscellaneous Logos Capital Fund LLP functions as pooled investment fund. The company is headquartered in Rehoboth, DE. | Miscellaneous |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Commercial Services |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The private company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Health Technology |
Logos Global Management LP
Logos Global Management LP Investment ManagersFinance Logos Global Management LP (Logos) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Arsani William and Graham Walmsley in 2019. They are owned and controlled by Logos Global Management GP LLC. Logos provides discretionary investment management services to privately offered pooled investment vehicles. | Finance |
Lifesci Acquisition II Corp.
 Lifesci Acquisition II Corp. Financial ConglomeratesFinance LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York, NY. | Finance |
- Beurs
- Insiders
- Graham Walmsley
- Ervaring
